Gene · 93649
Papers1,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A titin missense variant drives atrial electrical remodeling and is associated with atrial fibrillation. | Elife | 2026 | 41569083 | PubTator, text mining | PubMed |
| The circ_0042103/TAF15/NER axis regulates inflammation and DNA damage in pulpitis. | Stem Cell Res Ther | 2026 | 41530875 | PubTator, text mining | PubMed |
| MAPK14 converges on key transcriptional machinery to promote vascular smooth muscle cell degeneration in abdominal aortic aneurysm. | Signal Transduct Target Ther | 2026 | 41526342 | PubTator, text mining | PubMed |
| Vitamin D attenuates PCSK9-driven phenotypic switch of vascular smooth muscle cells and neointimal hyperplasia via SIRT6 activation. | Biochim Biophys Acta Mol Basis Dis | 2026 | 41391502 | PubTator, text mining | PubMed |
| Smooth muscle cell phenotypic modulation during atherosclerosis. | Vascul Pharmacol | 2026 | 41349733 | PubTator, text mining | PubMed |
| CDKN2B Inhibits Vascular Smooth Muscle Phenotypic Switching in Corpus Spongiosum Surrounding the Urethral Plate in Hypospadias. | Biomedicines | 2025 | 41595569 | PubTator, text mining | PubMed |
| Administration of a novel reprogramming formula improves cardiac function and decreases cardiac fibrosis in a myocardial infarction model. | JTCVS Open | 2025 | 41473092 | PubTator, text mining | PubMed |
| SREBP1-mediated lipogenesis promotes dedifferentiation and senescence of vascular smooth muscle cells through epigenetic remodeling. | Nat Commun | 2025 | 41453868 | PubTator, text mining | PubMed |
| NEXN targeting MYOCD by facilitating EMT-related β-catenin nuclear translocation modulates the metastasis of hepatocellular carcinoma. | iScience | 2025 | 41399508 | PubTator, text mining | PubMed |
| Deep learning the dynamic regulatory sequence code of cardiac organoid differentiation. | bioRxiv | 2025 | 41279701 | PubTator, text mining | PubMed |
| Long-read sequencing reveals HBV integration patterns and oncogenic impact on early-onset hepatocellular carcinoma. | Genome Res | 2025 | 40957658 | PubTator, text mining | PubMed |
| Engineering a serum response factor superactivator of smooth muscle gene expression with a condensate-forming domain. | Proc Natl Acad Sci U S A | 2025 | 40953276 | PubTator, text mining | PubMed |
| Advances in miRNA research: Unraveling the complexities of gene regulation. | Animal Model Exp Med | 2025 | 40947823 | PubTator, text mining | PubMed |
| Cytotoxicity of activator expression in CRISPR-based transcriptional activation systems. | Nat Commun | 2025 | 40877321 | PubTator, text mining | PubMed |
| Comorbidity of hypertension and lung cancer: interplay of genetics and environment. | Discov Oncol | 2025 | 40804226 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor 21 Promotes Vascular Smooth Muscle Cell Contractile Polarization via p38 Mitogen-Activated Protein Kinase-Promoted Serum Response Factor Phosphorylation. | Research (Wash D C) | 2025 | 40765997 | PubTator, text mining | PubMed |
| Poly(ADP-ribose) polymerase 1 orchestrates vascular smooth muscle cell homeostasis in arterial disease. | Exp Mol Med | 2025 | 40744995 | PubTator, text mining | PubMed |
| Substrate Stiffness Modulates TGF-β1-Induced Lineage Specification in Multipotent Vascular Stem Cells. | Cells | 2025 | 40277936 | PubTator, text mining | PubMed |
| The RNA-binding protein RBPMS inhibits smooth muscle cell-driven vascular remodeling in atherosclerosis and vascular injury. | Proc Natl Acad Sci U S A | 2025 | 39999164 | PubTator, text mining | PubMed |
| Novel Directly Reprogrammed Smooth Muscle Cells Promote Vascular Regeneration as Microvascular Mural Cells. | Circulation | 2025 | 39945059 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/93649/papers?page=2